Skip to content

Clinical trials

Phase 2 Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 2 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20033
20041
20063
20082
20091
20121
20132
20141
20151
20173
20182
20192
20202
20211
20223
20234
20245
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting6
Terminated4
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)8
Vanderbilt University Medical Center3
Clexio Biosciences Ltd.2
Marinus Pharmaceuticals2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Seaport Therapeutics2
University of California, San Diego2
Yale University2
Alan Davis1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder48
Major Depressive Disorder29
Mood Disorders16
Mental Disorders7
Depressive Disorder, Treatment-Resistant6
Bipolar Disorder5
Anxiety Disorders4
Depression, Postpartum2
Pregnancy Complications2
Puerperal Disorders2

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.